Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.
about
Efflux-mediated drug resistance in bacteria: an updateStructural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor designKinetic and X-Ray Structural Evidence for Negative Cooperativity in Substrate Binding to Nicotinate Mononucleotide Adenylyltransferase (NMAT) from Bacillus anthracisGenomewide screening for novel genetic variations associated with ciprofloxacin resistance in Bacillus anthracis.A rapid antimicrobial susceptibility test for Bacillus anthracis.Role of the water-metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV.Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridgeActivity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions.Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.Evaluation of the metS and murB loci for antibiotic discovery using targeted antisense RNA expression analysis in Bacillus anthracis.Efflux-mediated antimicrobial resistance.Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance.Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug Resistance.Activities of gyrase and topoisomerase IV on positively supercoiled DNA.
P2860
Q24609407-833432EC-A543-47CB-A8E7-EDC1DAA82D4FQ24643595-EFCA8465-0A7F-43F8-831D-058019DDCE27Q27652732-6C6A40F1-3833-4088-B36D-E9321E6D546AQ33962831-D3CE6A66-77BE-4A0A-9329-4E0963BA6B2EQ33962839-0CCE3343-7FF9-48DF-A21F-0358D9F25F03Q34119765-DDF5B3F8-1054-4C71-A2FB-777D0056D102Q34597404-965C6053-49B2-4C60-A77B-42860843799FQ35592636-B29A8D84-B84A-48BA-B406-DD760B4451B1Q35682250-5E8992A1-C4BE-4686-BA4D-7445B2993D03Q35759041-51DDE2EF-8E61-4410-B5EC-CC3223D67916Q36138147-FDC2ADBD-1CE2-4372-9EC2-8BFBA213705AQ36783606-E93D11EC-334C-43FA-9BF7-1D03F825C4CFQ37407949-90539FE1-32D1-4026-979B-148D66E03520Q46335874-4FD3D633-E6F3-4FCB-A0C0-32E07F26C6EFQ47766774-CC7D4F13-7A4E-4C4F-AD7A-4CD1830A2486
P2860
Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Activities of different fluoro ...... oring topoisomerase mutations.
@ast
Activities of different fluoro ...... oring topoisomerase mutations.
@en
type
label
Activities of different fluoro ...... oring topoisomerase mutations.
@ast
Activities of different fluoro ...... oring topoisomerase mutations.
@en
prefLabel
Activities of different fluoro ...... oring topoisomerase mutations.
@ast
Activities of different fluoro ...... oring topoisomerase mutations.
@en
P2093
P2860
P1476
Activities of different fluoro ...... oring topoisomerase mutations.
@en
P2093
Isabelle Podglajen
Laurent Gutmann
Patrick Grohs
P2860
P304
P356
10.1128/AAC.48.8.3024-3027.2004
P407
P577
2004-08-01T00:00:00Z